Allergy and Immunology · Mechanicsburg, PA
NPI
1093973091
Since 2008
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1700 Bent Creek Blvd., Suite 210
Mechanicsburg, PA, 17050
Phone (717) 791-2640
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
9,430 services
Medicare patients, 2024
207
Average age 72
Drug cost, 2024
$887K
1,151 prescriptions
Company payments, 2025
$23K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Krista M Todoric was code J2357 (injection, omalizumab, 5 mg), 5,130 times for 28 patients. In total Krista M Todoric billed 9,430 services in 26 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 5,130 | 28 | $29.96 | $154K |
| 95165 Treatment - Miscellaneous | Office | 530 | 19 | $9.95 | $5,272 |
| 95004 Test - Miscellaneous | Office | 511 | 11 | $2.50 | $1,276 |
| 95117 Treatment - Miscellaneous | Office | 287 | 61 | $7.85 | $2,254 |
| 96372 Injection Administration | Office | 229 | 46 | $10.37 | $2,374 |
| 99214 Office E&M - Established | Office | 157 | 84 | $87.78 | $14K |
| 95115 Treatment - Miscellaneous | Office | 106 | 21 | $6.65 | $705 |
| 94010 Pulmonary Function Testing | Office | 81 | 49 | $18.29 | $1,481 |
| 96160 E&M - Miscellaneous | Office | 43 | 36 | $2.13 | $91.56 |
| 99213 Office E&M - Established | Office | 27 | 24 | $62.54 | $1,689 |
| 99204 Office E&M - New | Office | 26 | 26 | $106.63 | $2,772 |
| 94060 Pulmonary Function Testing | Office | 12 | 11 | $28.68 | $344 |
By year: 2022 $240K for 7,855 services; 2023 $253K for 9,096 services; 2024 $232K for 9,430 services.
Medicare prescription drug claims, 2024
In 2024, the drug Krista M Todoric prescribed most often to Medicare patients was Montelukast Sodium, with 119 prescriptions and refills. In total Krista M Todoric wrote 1,151 Medicare prescriptions that cost $887K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 119 | 261 | 32 | $1,827 |
| Azelastine Hcl Generic | 109 | 178 | 50 | $3,244 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 91 | 158 | 24 | $94K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 76 | 96 | 24 | $58K |
| Spiriva Respimat Tiotropium Bromide | 62 | 86 | 16 | $44K |
| Mometasone Furoate Generic | 55 | 100 | 22 | $5,785 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 44 | 52 | 24 | $1,501 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 40 | 51 | 12 | $7,531 |
| Omeprazole Generic | 37 | 57 | Under 11 | $347 |
| Fluticasone Propionate Generic | 36 | 72 | 13 | $622 |
| Xhance Fluticasone Propionate | 35 | 45 | 12 | $38K |
| Famotidine Generic | 34 | 74 | 14 | $843 |
| Ipratropium Bromide Generic | 31 | 42 | 13 | $1,345 |
| Breo Ellipta Fluticasone/Vilanterol | 26 | 40 | Under 11 | $15K |
| Levocetirizine Dihydrochloride Generic | 24 | 60 | Under 11 | $1,095 |
Brand drugs: - claims; generic drugs: 627 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Krista M Todoric $23K ($23K in general payments such as food, travel and fees) from 22 companies. The largest payer was ARS Pharmaceuticals Operations, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. SPRY | 13 | $18K |
| Optinose US, Inc. | 2 | $1,524 |
| AstraZeneca Pharmaceuticals LP AZN | 35 | $906 |
| Regeneron Healthcare Solutions, Inc. REGN | 25 | $600 |
| GlaxoSmithKline, LLC. GSK | 25 | $390 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $330 |
| Genzyme Corporation SNY | 9 | $321 |
| Genentech USA, Inc. ROG.SW | 7 | $217 |
| Amgen Inc. AMGN | 9 | $168 |
| Lilly USA, LLC LLY | 5 | $99.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.